CAPR logo

CAPR
Capricor Therapeutics Inc

28,352
Mkt Cap
$212.13M
Volume
154.00
52W High
$20.75
52W Low
$4.30
PE Ratio
-2.56
CAPR Fundamentals
Price
$4.60
Prev Close
$4.64
Open
$4.45
50D MA
$6.39
Beta
1.19
Avg. Volume
1.17M
EPS (Annual)
-$1.15
P/B
2.51
Rev/Employee
$139,190.41
Loading...
Loading...
News
all
press releases
‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17%
Shkreli said that the company’s only asset, Dermiocel, will not yield positive results in the HOPE-3 study.
Stocktwits·2d ago
News Placeholder
More News
News Placeholder
What is B. Riley's Forecast for CAPR FY2025 Earnings?
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) - Equities research analysts at B. Riley lowered their FY2025 earnings estimates for shares of Capricor Therapeutics in a research report...
MarketBeat·11d ago
News Placeholder
What is Roth Capital's Estimate for CAPR FY2025 Earnings?
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) - Stock analysts at Roth Capital upped their FY2025 earnings per share estimates for shares of Capricor Therapeutics in a research note issued...
MarketBeat·11d ago
News Placeholder
B. Riley Research Analysts Cut Earnings Estimates for CAPR
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) - Equities research analysts at B. Riley cut their FY2026 EPS estimates for shares of Capricor Therapeutics in a research note issued to...
MarketBeat·12d ago
News Placeholder
CAPR FY2025 EPS Estimate Boosted by Cantor Fitzgerald
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for Capricor Therapeutics in a research report issued...
MarketBeat·12d ago
News Placeholder
HC Wainwright Has Positive Estimate for CAPR FY2025 Earnings
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) - Equities researchers at HC Wainwright lifted their FY2025 earnings per share estimates for shares of Capricor Therapeutics in a research...
MarketBeat·12d ago
News Placeholder
Investors Purchase High Volume of Capricor Therapeutics Put Options (NASDAQ:CAPR)
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Get Free Report) was the target of unusually large options trading on Tuesday. Stock investors purchased 17,427 put options on the company. This is an...
MarketBeat·14d ago
News Placeholder
Capricor Therapeutics (NASDAQ:CAPR) Issues Earnings Results
Capricor Therapeutics (NASDAQ:CAPR - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.54) earnings per share for the quarter, meeting...
MarketBeat·15d ago
News Placeholder
Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection
Capricor plans to resubmit its Duchenne therapy application in 2026 with new cardiac efficacy data.
Stocktwits·15d ago
News Placeholder
Preview: Capricor Therapeutics's Earnings
read more...
Benzinga·19d ago

Latest CAPR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.